EcoDrugPlus

Tubulin Beta 1 Class Vi

Ensembl ID : ENSNGAG00000021242
Gene Symbol: TUBB1
3 Cross references
186 Possible Orthologues:

Tubulin Beta 3 Class Iii

Ensembl ID : ENSNGAG00000015483
Gene Symbol: TUBB3
3 Cross references
144 Possible Orthologues:

Tubulin Beta 4a Class Iva

Ensembl ID : ENSNGAG00000019498
Gene Symbol: TUBB4A
3 Cross references
94 Possible Orthologues:

Tubulin Beta 4b Class Ivb

Ensembl ID : ENSNGAG00000001685
Gene Symbol: TUBB4B
3 Cross references
316 Possible Orthologues:

Tubulin Beta 6 Class V

Ensembl ID : ENSNGAG00000019902
Gene Symbol: TUBB6
3 Cross references
141 Possible Orthologues:

Tubulin Beta-2a Chain

Ensembl ID : ENSNGAG00000020746
Gene Symbol: LOC103732935
3 Cross references
183 Possible Orthologues:

Tubulin Beta-2b Chain

Ensembl ID : ENSNGAG00000021437
Gene Symbol: LOC103732934
3 Cross references
181 Possible Orthologues:

Tumor Protein P53

Ensembl ID : ENSNGAG00000010608
Gene Symbol: TP53
3 Cross references
253 Possible Orthologues:

Type-1 Angiotensin Ii Receptor

Ensembl ID : ENSNGAG00000001950
Gene Symbol: LOC103737006
3 Cross references
195 Possible Orthologues:

Tyrosinase

Ensembl ID : ENSNGAG00000013719
Gene Symbol: TYR
3 Cross references
266 Possible Orthologues:

Tyrosine Hydroxylase

Ensembl ID : ENSNGAG00000024133
Gene Symbol: TH
3 Cross references
187 Possible Orthologues:

Tyrosine Kinase 2

Ensembl ID : ENSNGAG00000003917
Gene Symbol: TYK2
3 Cross references
196 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).